Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data
Abstract Low-dose computed tomography screening can be used to diagnose lung cancer at a younger age compared to no screening. Real-world studies observing mortality after lung cancer diagnosis are subject to lead-time bias. This study developed a method using a nationwide cancer registry and stage...
Enregistré dans:
Auteurs principaux: | Szu-Chun Yang, Jung-Der Wang, Shi-Yi Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ea58d8495bae47c98e5d171cf56cb00c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
QALYs and medical costs saved from prevention of a cancer: Analysis of nation-wide real-world data of Taiwan with lifetime horizon
par: Wu-Wei Lai, et autres
Publié: (2021) -
Steering law considering biased loads for control moment gyroscopes
par: Yasuyuki NANAMORI, et autres
Publié: (2015) -
Real-world data analysis of patients with cancer of unknown primary
par: Sora Kang, et autres
Publié: (2021) -
Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients
par: You-Yi Chen, et autres
Publié: (2021) -
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy.
par: Emily S Sena, et autres
Publié: (2010)